Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
CLOV

CLOV - Clover Health Investments, Corp. Stock Price, Fair Value and News

1.03USD-0.02 (-1.90%)Market Closed

Market Summary

CLOV
USD1.03-0.02
Market Closed
-1.90%

CLOV Alerts

  • 1 major insider buys recently.
  • Big jump in Earnings (Y/Y)
  • Losses in recent quarter

CLOV Stock Price

View Fullscreen

CLOV RSI Chart

CLOV Valuation

Market Cap

501.0M

Price/Earnings (Trailing)

-3.13

Price/Sales (Trailing)

0.26

Price/Free Cashflow

-2.95

CLOV Price/Sales (Trailing)

CLOV Profitability

Return on Equity

-54.68%

Return on Assets

-23.81%

Free Cashflow Yield

-33.88%

CLOV Fundamentals

CLOV Revenue

Revenue (TTM)

2.0B

Rev. Growth (Yr)

7.74%

Rev. Growth (Qtr)

-43.42%

CLOV Earnings

Earnings (TTM)

-159.9M

Earnings Growth (Yr)

73.6%

Earnings Growth (Qtr)

72.8%

Breaking Down CLOV Revenue

Last 7 days

-6.3%

Last 30 days

14.3%

Last 90 days

42.5%

Trailing 12 Months

1.0%

How does CLOV drawdown profile look like?

CLOV Financial Health

Current Ratio

1.55

CLOV Investor Care

Shares Dilution (1Y)

1.58%

Diluted EPS (TTM)

-0.44

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20242.0B000
20232.9B2.6B2.2B1.9B
20222.1B2.6B3.0B3.5B
2021707.7M948.1M1.2B1.5B
2020514.9M567.6M620.2M672.9M
2019000462.3M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Clover Health Investments, Corp.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 17, 2024
loengard anna u
bought
18,600
0.93
20,000
-
May 16, 2024
loengard anna u
bought
29,952
0.96
31,200
-
May 16, 2024
loengard anna u
bought
2,791
0.94
2,970
-
May 14, 2024
soares karen
sold (taxes)
-10,691
1.02
-10,482
general counsel & secretary
May 09, 2024
sharp aric r
sold (taxes)
-11,692
0.86
-13,596
ceo of value based care
May 08, 2024
toy andrew
sold (taxes)
-74,269
0.87
-85,367
chief executive officer
Apr 18, 2024
priest brady patrick
sold (taxes)
-20,422
0.63
-32,416
ceo of home care
Apr 03, 2024
reynoso jamie l.
sold (taxes)
-4,094
0.76
-5,387
ceo, medicare advantage
Apr 01, 2024
toy andrew
sold (taxes)
-237,423
0.77
-308,341
chief executive officer
Mar 15, 2024
soares karen
sold (taxes)
-4,134
0.8
-5,168
general counsel & secretary

1–10 of 50

Which funds bought or sold CLOV recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 24, 2024
Cetera Investment Advisers
new
-
14,226
14,226
-%
May 16, 2024
Jaffetilchin Investment Partners, LLC
added
30.24
3,132
39,494
-%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-50.7
-703,813
491,413
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
added
1.73
-48,447
271,011
-%
May 15, 2024
Squarepoint Ops LLC
reduced
-36.22
-81,788
92,916
-%
May 15, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
new
-
3,629
3,629
-%
May 15, 2024
Steward Partners Investment Advisory, LLC
unchanged
-
-264
1,326
-%
May 15, 2024
Man Group plc
sold off
-100
-29,393
-
-%
May 15, 2024
Voya Investment Management LLC
added
23.22
3,473
129,520
-%
May 15, 2024
BANK OF AMERICA CORP /DE/
reduced
-64.03
-221,805
95,050
-%

1–10 of 41

Are Funds Buying or Selling CLOV?

Are funds buying CLOV calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CLOV
No. of Funds

Unveiling Clover Health Investments, Corp.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
6.09%
24,331,680
SC 13G/A
Jul 07, 2023
blackrock inc.
2.0%
7,772,104
SC 13G/A
Feb 09, 2023
vanguard group inc
8.38%
32,158,748
SC 13G/A
Feb 03, 2023
blackrock inc.
7.1%
27,124,981
SC 13G
Oct 04, 2022
chachacha spac c, llc
4.99%
19,132,693
SC 13D/A
Mar 10, 2022
greenoaks capital partners llc
1.3%
5,073,790
SC 13G/A
Feb 09, 2022
vanguard group inc
7.83%
25,887,351
SC 13G/A
Feb 12, 2021
integrated core strategies (us) llc
0.0%
12,933
SC 13G/A
Feb 09, 2021
greenoaks capital partners llc
40.2%
96,331,338
SC 13G
Feb 04, 2021
linden capital l.p.
0.1%
70,365
SC 13G/A

Recent SEC filings of Clover Health Investments, Corp.

View All Filings
Date Filed Form Type Document
Jun 13, 2024
8-K
Current Report
May 29, 2024
8-K
Current Report
May 20, 2024
4
Insider Trading
May 16, 2024
4
Insider Trading
May 13, 2024
4
Insider Trading
May 10, 2024
3
Insider Trading
May 10, 2024
4
Insider Trading
May 07, 2024
10-Q
Quarterly Report
May 07, 2024
8-K
Current Report
Apr 26, 2024
ARS
ARS

Peers (Alternatives to Clover Health Investments, Corp.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
457.7B
379.5B
-3.65% 0.77%
29.8
1.21
12.96% -25.81%
94.9B
206.0B
-3.75% 23.43%
24.62
0.46
12.55% -43.95%
89.3B
66.7B
7.45% 22.04%
16.32
1.34
9.59% -4.59%
76.6B
360.9B
6.23% -16.98%
10.46
0.21
9.07% 78.83%
36.8B
155.5B
-12.24% -2.53%
13.46
0.24
6.34% 84.42%
12.6B
14.7B
4.84% 32.82%
15.48
0.86
7.99% 19.23%
12.5B
12.3B
4.47% 45.25%
15.28
1.01
5.77% 58.74%
MID-CAP
8.1B
2.3B
-4.83% -0.18%
28.7
3.55
5.96% 18.29%
6.2B
3.0B
-5.43% -3.06%
-544.54
2.06
10.92% -104.06%
2.2B
1.5B
0.05% 19.70%
34.9
1.5
19.34% 40.15%
2.0B
3.5B
-9.25% -51.02%
14.21
0.59
-27.67% -62.40%
SMALL-CAP
1.9B
1.1B
7.13% 25.50%
28.96
1.75
11.45% 30.74%
1.3B
3.0B
-3.72% 59.10%
-7.38
0.42
4.98% 4.88%
53.4M
-
13.00% -23.39%
-3.54
-
- -1.05%
20.7M
21.6M
-6.30% 25.29%
40.75
0.96
9.04% -57.88%

Clover Health Investments, Corp. News

Latest updates
Simply Wall St40 hours ago
MarketBeat10 Jun 202407:14 pm

Clover Health Investments, Corp. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Revenue-43.4%346,922613,143482,066513,628321,992898,791856,817846,700874,379432,036427,163412,472200,325166,233169,069172,081165,505-
Gross Profit23.3%81,76066,30763,10776,67447,2035,14617,018-12,08612,657--9,162-46,031------
Operating Expenses-45.3%369,625675,257523,535542,435401,6901,006,134930,913949,427961,860618,825576,416594,334319,413233,862190,687148,911192,135-
  S&GA Expenses-2.8%44,56945,86541,74742,43357,64455,34847,83247,04057,69755,17745,84645,64638,61841,03229,84721,46828,483-
Interest Expenses----7.00-1364043904034034041,2111,17510,4309,2688,4777,815-
Net Income72.8%-19,170-70,472-41,469-28,814-72,606-84,226-75,489-104,362-75,490-187,201-34,527-317,611-48,417-126,39112,7585,403-28,162-17.63
Net Income Margin26.0%-0.08*-0.11*-0.09*-0.09*-0.11*-0.10*-0.15*-0.16*-0.29*-0.40*-0.44*-0.51*-0.22*-0.20*-0.02*-0.64*-0.71*-0.79*
Free Cashflow111.1%25,490-229,031-19,02452,81978,781-295,667101,396-39,344-57,200-80,414-45,321-64,346-92,968-59,967-34,81713,011-37,418-
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Assets17.7%6725711,0601,2587378091,5582,0632,6809519521,216867267829829583337
  Current Assets29.2%5534289161,1291,2746251,4601,8612,4917535597188091901.001.00-253
    Cash Equivalents78.9%20811629931019118638332427430020248640592.0090.0010711268.00
  Net PPE2.5%5.005.005.005.005.006.003.002.002.002.002.002.002.002.00---2.00
  Goodwill------12.00---1.00---1.00---1.00
Liabilities33.4%3792847389271,1304521,1661,6362,19041154090127843331.0029.00-378
  Current Liabilities36.5%3562617199081,1104321,1281,5992,1523722301961731642.000.001.00142
  Long Term Debt-------20.0020.0020.0020.0020.0020.005.00106---58.00
    LT Debt, Non Current-------20.0020.0020.0020.0020.0020.0024.00106---58.00
Shareholder's Equity2.1%2922863223313233573924274905404123155895.005.005.000.00-
  Retained Earnings-0.9%-2,178-2,159-2,089-2,047-2,019-1,946-1,871-1,796-1,692-1,616-1,429-1,395-1,077-1,028-2.37-0.07-0.02-891
  Additional Paid-In Capital1.2%2,4902,4612,4282,3952,3592,3192,2812,2382,1952,1541,8391,7061,6634127.005.000.00403
Shares Outstanding0.9%486482481-47947647647647341341540837689.0089.0089.0088.0088.00
Minority Interest----------4.004.004.004.004.00----
Float----360---839---5,469---926--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Cashflow From Operations111.3%25,935-229,295-18,78153,17379,032-291,790101,655-39,171-57,042-80,176-45,126-64,155-92,869-59,904-34,65013,232-37,176-17.63
  Share Based Compensation-13.1%28,79833,13633,07036,10838,61739,09442,64441,92740,64031,18146,80343,02642,7132,1291,5011,4711,977-
Cashflow From Investing-89.0%9,18583,662-20,32166,49110,18112,656-43,38989,35336,513-106,491-242,345170,865-257,47667,5571,500-14,16382,510-
Cashflow From Financing88.7%-3,359-29,617-1,963-147-2,13482,478132458-5,608284,3713,988-25,470662,504-5,03715,470-4,151-43818.00
  Buy Backs306.2%3,3598271,9944172,98242.002761055,939-147-------
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

CLOV Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:  
Premiums earned, net (Net of ceded premiums of $101 and $122 for the three months ended March 31, 2024 and 2023, respectively)$ 341,722$ 317,086
Other income5,2004,906
Total revenues346,922321,992
Operating expenses:  
Net medical claims incurred265,162274,789
Salaries and benefits59,22368,981
General and administrative expenses44,56957,644
Premium deficiency reserve benefit0(1,810)
Depreciation and amortization318279
Restructuring costs3531,807
Total operating expenses369,625401,690
Loss from continuing operations(22,703)(79,698)
Loss on investment4670
Net loss from continuing operations(23,170)(79,698)
Net income from discontinued operations (Note 17)4,0007,092
Net loss$ (19,170)$ (72,606)
Continuing Operations:  
Basic weighted average number of Class A and Class B common shares and common share equivalents outstanding (in shares)486,374,644478,805,067
Diluted weighted average number of Class A and Class B common shares and common share equivalents outstanding (in shares)486,374,644478,805,067
Basic net loss per share (in dollars per share)$ (0.05)$ (0.17)
Diluted net loss per share (in dollars per share)$ (0.05)$ (0.17)
Discontinued operations:  
Basic weighted average number of Class A and Class B common shares and common share equivalents outstanding (in shares)486,374,644478,805,067
Diluted weighted average number of Class A and Class B common shares and common share equivalents outstanding (in shares)567,451,166566,629,082
Basic earnings per share (in dollars per share)$ 0.01$ 0.01
Diluted earnings per share (in dollars per share)$ 0.01$ 0.01
Net unrealized (loss) gain on available-for-sale investments$ (190)$ 2,343
Comprehensive loss$ (19,360)$ (70,263)

CLOV Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets  
Cash and cash equivalents$ 208,255$ 116,407
Short-term investments9,12012,218
Investment securities, available-for-sale (Amortized cost: 2024: $119,528; 2023: $101,412)118,056100,702
Investment securities, held-to-maturity (Fair value: 2024: $6,853; 2023: $6,778)6,9236,902
Accrued retrospective premiums70,60722,076
Other receivables22,53316,666
Healthcare receivables83,86764,164
Surety bonds and deposits740542
Prepaid expenses16,76114,418
Other assets, current4,9491,404
Assets related to discontinued operations (Note 17)10,92672,471
Total current assets552,737427,970
Investment securities, available-for-sale (Amortized cost: 2024: $98,221; 2023: $121,868)97,133120,208
Investment securities, held-to-maturity (Fair value: 2024: $693; 2023: $692)792793
Property and equipment, net5,2095,082
Operating lease right-of-use assets3,1243,382
Other intangible assets2,9902,990
Other assets, non-current9,78510,246
Total assets671,770570,671
Current liabilities  
Unpaid claims238,602135,737
Accounts payable and accrued expenses35,40837,184
Accrued salaries and benefits28,32720,951
Deferred revenue03,099
Operating lease liabilities1,6231,665
Liabilities related to discontinued operations (Note 17)50,62260,099
Total current liabilities356,389261,115
Long-term operating lease liabilities2,7172,998
Other liabilities, non-current20,19020,164
Total liabilities379,296284,277
Commitments and Contingencies (Note 13)
Stockholders' equity  
Additional paid-in capital2,490,0362,461,238
Accumulated other comprehensive loss(2,560)(2,370)
Accumulated deficit(2,178,964)(2,159,794)
Less: Treasury stock, at cost; 11,613,745 and 7,912,750 shares held at March 31, 2024 and December 31, 2023, respectively(16,088)(12,729)
Total stockholders' equity292,474286,394
Total liabilities and stockholders' equity671,770570,671
Common Class A  
Stockholders' equity  
Common stock, value4140
Common Class B  
Stockholders' equity  
Common stock, value99
Related party  
Current liabilities  
Due to related parties, net8811,363
Other liabilities, current8811,363
Nonrelated party  
Current liabilities  
Due to related parties, net9261,017
Other liabilities, current$ 926$ 1,017
CLOV
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. The company was incorporated in 2014 and is based in Franklin, Tennessee.
 CEO
 WEBSITEcloverhealth.com
 INDUSTRYHealthcare Plans
 EMPLOYEES656

Clover Health Investments, Corp. Frequently Asked Questions


What is the ticker symbol for Clover Health Investments, Corp.? What does CLOV stand for in stocks?

CLOV is the stock ticker symbol of Clover Health Investments, Corp.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Clover Health Investments, Corp. (CLOV)?

As of Wed Jun 12 2024, market cap of Clover Health Investments, Corp. is 510.69 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CLOV stock?

You can check CLOV's fair value in chart for subscribers.

What is the fair value of CLOV stock?

You can check CLOV's fair value in chart for subscribers. The fair value of Clover Health Investments, Corp. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Clover Health Investments, Corp. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CLOV so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Clover Health Investments, Corp. a good stock to buy?

The fair value guage provides a quick view whether CLOV is over valued or under valued. Whether Clover Health Investments, Corp. is cheap or expensive depends on the assumptions which impact Clover Health Investments, Corp.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CLOV.

What is Clover Health Investments, Corp.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Jun 12 2024, CLOV's PE ratio (Price to Earnings) is -3.19 and Price to Sales (PS) ratio is 0.26. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CLOV PE ratio will change depending on the future growth rate expectations of investors.